Lectures

New clinical data for left atrial appendage occlusion therapy, presented & published in 2016. Includes a critical review of the Stroke Prevention section in the 2016 ESC Atrial Fibrillation guidelines.

Why might LAA occlusion therapy be cost effective, despite a high procedural cost? This presentation is an overview of the health economics data available for left atrial appendage closure therapy.

Review of new left atrial appendage occlusion devices that came to market (CE-mark) or underwent a major redesign in 2016.

Anatomy of left atrium specific focus on left atrial appendage. Important factors and anatomical landmarks for LAA occlusion.

Step-by-step device implantation of an Amplatzer Amulet left atrial appendage occluder implantation using Philips EchoNavigator imaging fusion technology.

New tools and strategies for imaging. New tools: Philips EchoNavigator, future micro TEE probes etc. 

Sizing in Left Atrial Appendage Occlusion therapy device implantation is still under debate. There are different devices and different methodologies discussed, while taking anatomical differences into account.

Device thrombosis is still one of the most feared complications with left atrial appendage occlusion therapy. Post implant therapies are needed to avoid this complication. This presentation guides throughout the decision making process.

Why do LAA closure leaks occur? Is there a clinical effect? This presentation provides methods to assess leaks and anecdotal evidence of how to potential treat those.